Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation

BACKGROUND: Breast cancer is the leading cause of cancer-related mortality in women worldwide. Long non-coding RNAs (lncRNAs) are of critical importance in tumor drug resistance. Herein, this study aims to determine the roles of lncRNA ZEB1-AS1 in drug resistance of breast cancer involving microRNA-...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Jin, Yuan, Yuan, Zhang, Lili, Yu, Shaorong, Lu, Jianwei, Feng, Jifeng, Hu, Sainan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092489/
https://www.ncbi.nlm.nih.gov/pubmed/32210737
http://dx.doi.org/10.1186/s12935-020-1164-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092489/
https://www.ncbi.nlm.nih.gov/pubmed/32210737
http://dx.doi.org/10.1186/s12935-020-1164-8

Ejemplares similares